High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
UnitedHealth Group Inc (NYSE:UNH, XETRA:UNH) shares rose more than 5% to about $397 on Thursday after Bank of America upgraded the stock to ‘Buy,’ citing improving medical cost trends and a more favorable risk-reward setup heading into upcoming earnings. The firm also raised its price target...
BofA upgraded UnitedHealth to Buy, citing improving medical cost trends and a favorable Q2 earnings setup.
UNH raises its dividend again, extending a long streak of annual increases despite a smaller hike.
UnitedHealth Group shares surged to lead the Dow higher Thursday after the insurance giant's stock was upgraded by Bank of America.
Shares of UnitedHealth Group receive votes of confidence from analysts at BofA Securities and Morgan Stanley.
BofA analyst Kevin Fischbeck upgraded UnitedHealth’s rating to ‘Buy’ from ‘Neutral’ and raised the price target to $450 from $420.
The Dow Jones Industrial Average rose Thursday while other indexes lagged behind thanks in part to gains in bank and healthcare stocks. “This is a non-chip rally,” said Jay Hatfield, chief executive officer and portfolio manager at Infrastructure Capital Advisors.
UnitedHealth Group, CVS Health and other S&P 500 health insurance giant rallied on Thursday morning after price-target hikes from Morgan Stanley and a UNH upgrade from BofA. The analysts highlighted moderating health care utilization trends and a tailwind to profitability from deploying AI.
UNH, DCI, LOW, PLUS and TD stand out for cautious investors as markets weigh inflation, growth and geopolitics amid recent dividend hikes.
US stocks were expected to head in different directions on Thursday morning, as oil prices retreat but tech earnings overnight disappointed investors. Dow Jones futures were called 0.8% higher, but the S&P 500 was off 0.4% and Nasdaq futures were down 1.3%. The latter pair were...
Pre-Market Stock Futures: Futures are trading mixed after the AI/Datacenter/Storage/Technology rally took a day off on Wednesday. By the close, all of the major indices finished the day down in a big way. The same issues that have added pressure to stocks once again showed up at the party, as rising interest rates and oil ... Here Are Thursday’s Top Wall Street Analyst Research Calls: Broadcom, CMS Energy, Commercial Metals, FedEx Freight, Medtronic, Murphy Oil, Sherwin-Williams, TeraWulf, and M
The Social Security Administration (SSA) set the 2026 cost-of-living adjustment (COLA) at 2.8%, lifting the average retired worker’s benefit from $2,015 to $2,071 per month. That extra $56 sounds fine on paper. Then the Medicare Part B premium notice arrives, the Medigap renewal letter shows up, and the math gets tighter than expected. One retiree ... Why Social Security’s 2.8% COLA Isn’t Keeping Up With What Retirees Actually Spend on Healthcare
FEATURE The artificial-intelligence rally may be grinding to a halt. Technology stocks were getting hit hard on Thursday after mediocre revenue guidance from Broadcom caused investors to question how fast AI demand will accelerate.
Investing.com -- Bank of America upgraded UnitedHealth Group to Buy from Neutral and raised its price target to $450 from $420 per share in a note on Thursday, citing improving medical cost trends and a favorable setup heading into second-quarter earnings, analyst Kevin Fischbeck said.
UnitedHealth, The Cigna, Humana, Centene and Molina have been highlighted in this Industry Outlook article.
FTSE 100 up 8 points to 10,341 Oil prices soften on Israel-Lebanon ceasefire CMC Markets nears five-year high on results 2.56pm: Toddlers' picnic on Wall Street As expected, Wall Street has opened like a toddlers' picnic, with everyone heading off in different...
Aging demographics, sound Medicare premiums, digital healthcare adoption and increased M&A activity are likely to drive the performance of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and MOH are poised to benefit from favorable industry prospects.
The Mairs & Power, an investment firm, released the first-quarter 2026 investor letter for the “Mairs & Power Balanced Fund.” A copy of the letter can be downloaded here. The fund returned -1.77% in the first quarter of 2026, outperforming its benchmark composite index decline of -2.68% as strong stock selection and exposure to Utilities […]
Eli Lilly and Company just secured a big win as it looks to expand GLP-1 access, mending its partnership with top pharmacy benefit manager CVS Health.
While Cigna has lagged behind the broader healthcare sector over the past year, Wall Street analysts remain highly bullish about the stock’s prospects.
Massachusetts has filed a lawsuit against UnitedHealth Group, alleging the company exaggerated illness severity for Medicaid patients to obtain higher payments. The case focuses on claimed inflation of patient risk scores within the state’s Medicaid program and UnitedHealth has denied any wrongdoing. The lawsuit introduces additional legal and reputational questions for UnitedHealth Group that go beyond routine operational updates. UnitedHealth Group (NYSE:UNH) is facing this legal...
Growth, not yield, is the deciding factor.
UnitedHealth Group (NYSE:UNH) is a stock worth owning for decades because the aging of America makes its cash flows close to legislatively guaranteed, and almost nothing in the public markets matches the combination of scale, integration, and shareholder return discipline this company has built around that demographic certainty. Pillar One: A Business Built to Last ... Forget Market Volatility: This Cash-Flow Machine Is a Once-in-a-Generation Buy and Never Sell Stock
UNH plans to eliminate nearly two-thirds of pediatric prior authorizations by year-end, aiming to speed care access and reduce provider paperwork.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
